PT2841426T - Derivados de quinolina antibacterianos - Google Patents

Derivados de quinolina antibacterianos

Info

Publication number
PT2841426T
PT2841426T PT137208757T PT13720875T PT2841426T PT 2841426 T PT2841426 T PT 2841426T PT 137208757 T PT137208757 T PT 137208757T PT 13720875 T PT13720875 T PT 13720875T PT 2841426 T PT2841426 T PT 2841426T
Authority
PT
Portugal
Prior art keywords
quinoline derivatives
antibacterial quinoline
antibacterial
derivatives
quinoline
Prior art date
Application number
PT137208757T
Other languages
English (en)
Portuguese (pt)
Inventor
Emile Georges Guillemont Jerôme
Madeleine Simone Motte Magali
Francis Alain Lançois David
Mia Albert Balemans Wendy
Robert Gaston Thomas Sébastien
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of PT2841426T publication Critical patent/PT2841426T/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4709Non-condensed quinolines and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • A61P31/06Antibacterial agents for tuberculosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT137208757T 2012-04-27 2013-04-26 Derivados de quinolina antibacterianos PT2841426T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP12165882 2012-04-27

Publications (1)

Publication Number Publication Date
PT2841426T true PT2841426T (pt) 2016-11-23

Family

ID=48325651

Family Applications (1)

Application Number Title Priority Date Filing Date
PT137208757T PT2841426T (pt) 2012-04-27 2013-04-26 Derivados de quinolina antibacterianos

Country Status (15)

Country Link
US (1) US9617244B2 (enExample)
EP (1) EP2841426B1 (enExample)
JP (1) JP6153603B2 (enExample)
KR (1) KR102110366B1 (enExample)
CN (1) CN104254528B (enExample)
AU (1) AU2013254670B2 (enExample)
CA (1) CA2869453C (enExample)
DK (1) DK2841426T3 (enExample)
EA (1) EA038350B1 (enExample)
ES (1) ES2607879T3 (enExample)
IN (1) IN2014MN02358A (enExample)
MX (1) MX358506B (enExample)
PL (1) PL2841426T3 (enExample)
PT (1) PT2841426T (enExample)
WO (1) WO2013160431A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013160435A1 (en) * 2012-04-27 2013-10-31 Janssen Pharmaceutica Nv Antibacterial quinoline derivatives
WO2018048882A1 (en) 2016-09-06 2018-03-15 The Research Foundation For The State University Of New York Positron imaging tomography imaging agent composition and method for bacterial infection
EP4493551A1 (en) 2022-03-14 2025-01-22 Slap Pharmaceuticals LLC Multicyclic compounds

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2270123A1 (en) 1996-10-28 1998-05-07 Department Of The Army, U.S. Government Compounds, compositions and methods for treating antibiotic-resistant infections
US6103905A (en) 1997-06-19 2000-08-15 Sepracor, Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
GB0118238D0 (en) * 2001-07-26 2001-09-19 Smithkline Beecham Plc Medicaments
ATE463482T1 (de) 2002-07-25 2010-04-15 Janssen Pharmaceutica Nv Chinolinderivate und deren verwendung als mycobakterielle inhibitoren
AP2507A (en) 2004-01-23 2012-11-16 Janssen Pharmaceutica Nv Quinoline derivatives and use thereof as mycobacterial inhibitors.
KR101150172B1 (ko) * 2004-01-23 2012-05-25 얀센 파마슈티카 엔.브이. 치환된 퀴놀린 및 마이코박테리아 저해제로서의 용도
AU2005210036B2 (en) 2004-01-29 2010-12-23 Janssen Pharmaceutica N.V. Quinoline derivatives for use as mycobacterial inhibitors
ATE390925T1 (de) 2004-05-28 2008-04-15 Janssen Pharmaceutica Nv Verwendung von substituierten chinolin-derivaten zur behandlung von arzneimittelresistenten mycobakteriellen erkrankungen
WO2005123081A2 (en) 2004-06-22 2005-12-29 Janssen Pharmaceutica N.V. (2-benzyl-4-{4-[1-(tetrahydrofuran-3-carbonyl)-pyrrolidin-3-yl]-piperazin-1-yl}-piperidin-1-yl)-(3,5-trifluoromethyl-phenyl))-methanone for the treatment of schizophrenia
JP2008515395A (ja) 2004-09-28 2008-05-15 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 細菌のatp合成酵素の結合ドメイン
EE05394B1 (et) 2004-12-24 2011-04-15 Janssen Pharmaceutica N.V. Kinoliinihendid kasutamiseks latentse tuberkuloosi ravis
EE05697B1 (et) 2005-06-08 2014-02-17 Janssen Pharmaceutica N.V. Kinoliini derivaadid kui antibakteriaalsed toimeained
JO3270B1 (ar) 2005-06-28 2018-09-16 Janssen Pharmaceutica Nv مشتقات كوينولين بصفة عوامل مضادة للبكتيريا
JO2752B1 (en) 2005-06-28 2014-03-15 شركة جانسين فارماسوتيكا ان. في Quinoline derivatives acting as antibacterial agents
NZ564340A (en) 2005-06-28 2011-02-25 Janssen Pharmaceutica Nv Quinoline derivatives as antibacterial agents
JO3077B1 (ar) 2005-07-28 2017-03-15 Janssen Pharmaceutica Nv مشتقات كوينولين مضادة للبكتيريا
JO2952B1 (en) 2005-08-03 2016-03-15 جانسين فارماسوتيكا ان. في Quinoline derivatives acting as antibacterial agents
JO2855B1 (en) 2005-08-03 2015-03-15 شركة جانسين فارماسوتيكا ان. في Quinoline derivatives acting as antibacterial agents
JO2837B1 (en) 2005-08-03 2014-09-15 جانسن فارمسيتكا ان في Quinoline derivatives acting as antibacterial agents
JO2970B1 (en) 2006-12-06 2016-03-15 جانسين فارماسوتيكا ان. في Quinoline antibacterial derivatives
JO2685B1 (en) 2006-12-06 2013-03-03 جانسين فارماسوتيكا ان في Quinoline antibacterial derivatives
JO3271B1 (ar) 2006-12-06 2018-09-16 Janssen Pharmaceutica Nv مشتقات الكوينولين المضادة للجراثيم
JO2684B1 (en) 2006-12-06 2013-03-03 جانسين فارماسوتيكا ان في Quinoline antibacterial derivatives
JO2683B1 (en) * 2006-12-06 2013-03-03 جانسين فارماسوتيكا ان. في Quinoline antibacterial derivatives
JO2725B1 (en) * 2006-12-06 2013-09-15 جانسين فارماسوتيكا ان. في Quinoline antibacterial derivatives
US20110059948A1 (en) * 2008-01-14 2011-03-10 Jyoti Chattopadhyaya Quinoline, naphthalene and conformationally constrained quinoline or naphthalene derivatives as anti-mycobacterial agents
WO2013160435A1 (en) * 2012-04-27 2013-10-31 Janssen Pharmaceutica Nv Antibacterial quinoline derivatives

Also Published As

Publication number Publication date
MX358506B (es) 2018-08-22
MX2014013055A (es) 2014-12-10
WO2013160431A1 (en) 2013-10-31
JP2015514795A (ja) 2015-05-21
IN2014MN02358A (enExample) 2015-08-14
EA201491971A1 (ru) 2015-02-27
CA2869453A1 (en) 2013-10-31
EA038350B1 (ru) 2021-08-12
AU2013254670B2 (en) 2017-03-30
HK1201520A1 (en) 2015-09-04
ES2607879T3 (es) 2017-04-04
US9617244B2 (en) 2017-04-11
DK2841426T3 (en) 2017-01-09
PL2841426T3 (pl) 2017-03-31
KR102110366B1 (ko) 2020-05-14
CN104254528A (zh) 2014-12-31
US20150051244A1 (en) 2015-02-19
AU2013254670A1 (en) 2014-10-16
KR20150013148A (ko) 2015-02-04
EP2841426A1 (en) 2015-03-04
CA2869453C (en) 2021-03-02
EP2841426B1 (en) 2016-09-28
CN104254528B (zh) 2017-06-06
JP6153603B2 (ja) 2017-06-28

Similar Documents

Publication Publication Date Title
IL239109A0 (en) State-of-the-art quinolone derivatives
ZA201600514B (en) Quinoline derivative
ZA201409422B (en) Benzimidazole-proline derivatives
ZA201408876B (en) Pyrrolotriazinone derivatives
EP2828257A4 (en) ANTIBACTERIAL COMPOUNDS
ZA201502175B (en) Oxazolidin-2-one-pyrimidine derivatives
IL236295A (en) The history of indanesulfamide
PL2841425T3 (pl) Antybakteryjne pochodne chinoliny
ZA201405108B (en) Substituted phenylazole derivative
GB201206384D0 (en) Antibacterial drug derivatives
PT2873660T (pt) Derivado de indolecarboxamida
PT2841426T (pt) Derivados de quinolina antibacterianos
ZA201501640B (en) Tricyclic tetrahydroquinoline antibacterial agents
AP2015008503A0 (en) Antibacterial compounds
IL239207A0 (en) Antibacterial compounds
GB201206385D0 (en) Antibacterial drug derivatives
GB201206383D0 (en) Antibacterial drug derivatives
GB201119961D0 (en) Antibacterial derivatives
GB201119958D0 (en) Antibacterial derivatives